Format

Send to

Choose Destination
See comment in PubMed Commons below
Hum Pathol. 2014 May;45(5):1065-70. doi: 10.1016/j.humpath.2014.01.003. Epub 2014 Jan 23.

Y-chromosome status identification suggests a recipient origin of posttransplant non-small cell lung carcinomas: chromogenic in situ hybridization analysis.

Author information

  • 1Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH 43210.
  • 2Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210.
  • 3Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210.
  • 4Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH 43210. Electronic address: Konstantin.Shilo@OSUMC.edu.

Abstract

Owing to the need of lifelong immunosuppression, solid-organ transplant recipients are known to have an increased risk of posttransplant malignancies including lung cancer. Posttransplant neoplastic transformation of donor-derived cells giving rise to hematopoietic malignancies, Kaposi sarcoma, and basal cell carcinoma in nongraft tissues has been reported. The goal of this study was to assess the cell origin (donor versus recipient derived) of posttransplant non-small cell lung carcinomas (NSCLCs) in kidney and heart transplant recipients. An institutional database search identified 2557 kidney and heart transplant recipients in 8 consecutive years. Among this cohort, 20 (0.8%) renal and 18 (0.7%) heart transplant recipients developed NSCLC. The study cohort comprised 6 of 38 NSCLCs arising in donor-recipient sex-mismatched transplant patients. The tumor cell origin was evaluated by chromogenic in situ hybridization with Y-chromosome probe on formalin-fixed, paraffin-embedded tissues. Y-chromosome was identified in 97% ± 1% (range from 92% to 99%) of all types of nucleated cells in male control tissues. In all 5 NSCLCs from male recipients of female donor organ, Y-chromosome was identified in 97% ± 2% (range from 92% to 100%) of tumor cells, statistically equivalent to normal control (P < .001). No Y-chromosome was identified in NSCLC cells from a female recipient of male kidney. These findings suggest a recipient derivation of NSCLC arising in kidney and heart transplant recipients. A combination of histologic evaluation and chromogenic in situ hybridization with Y-chromosome analysis allows reliable determination of tissue origin in sex-mismatched solid-organ transplant recipients and may aid in management of posttransplant malignancy in such cases.

Copyright © 2014 Elsevier Inc. All rights reserved.

KEYWORDS:

Chromogenic in situ hybridization for Y-chromosome; Post–solid-organ transplantation lung cancer

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk